Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM86GP is a member of the family with sequence similarity 86 and is annotated as a pseudogene in humans. Pseudogenes are sequences of DNA that closely resemble established genes but are typically nonfunctional due to accumulated mutations, lost regulatory elements, or structural disruptions that prevent transcription and translation into a functional protein[1][4]. While some pseudogenes may have regulatory roles at the RNA level—such as acting as antisense RNAs, sources of small interfering RNAs (siRNAs), or competing endogenous RNAs—there is no direct evidence or specific literature supporting any function for FAM86GP. In research and clinical settings, most pseudogenes, including FAM86GP, remain largely unstudied, and are not regarded as molecular targets, disease biomarkers, or druggable elements[1][3][4][5]. Note: Pseudogenes like FAM86GP sometimes complicate genetic studies due to sequence similarity to functional genes, which can lead to misannotation or PCR amplification bias[4][5]. For structured data, this entry should be flagged as non-target due to its pseudogene status.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 86 member G, pseudogene (FAM86GP).